The Anti-Phospholipid Antibody (APL) IgM test detects IgM autoantibodies against phospholipids, which are essential components of cell membranes. It is used to diagnose antiphospholipid syndrome (APS) and assess the risk of blood clots, recurrent miscarriages, and autoimmune diseases like systemic lupus erythematosus (SLE).
✅ Diagnose Antiphospholipid Syndrome (APS)
✅ Evaluate unexplained blood clots (venous or arterial thrombosis)
✅ Investigate recurrent miscarriages (especially after 10 weeks of pregnancy)
✅ Assess autoimmune disorders, particularly systemic lupus erythematosus (SLE)
| Result | Interpretation |
|---|---|
| Negative | No detectable Anti-Phospholipid IgM antibodies |
| Low Positive | Possible mild autoimmune activity, may not be clinically significant |
| Moderate to High Positive | Suggests increased risk of thrombosis, pregnancy complications, or APS |
🔹 IgM APL antibodies are often short-lived and may appear in infections or temporary immune responses.
🔹 IgG APL antibodies are more strongly associated with Antiphospholipid Syndrome (APS) and long-term clotting risk.
🔹 Persistent positivity (≥ 12 weeks apart) is required to confirm APS diagnosis.
Primary Antiphospholipid Syndrome (APS) → Autoimmune disorder leading to blood clots and pregnancy loss.
Secondary APS → Occurs in SLE, rheumatoid arthritis, or other autoimmune diseases.
Unexplained Thrombosis → Recurrent deep vein thrombosis (DVT), stroke, or pulmonary embolism.
Obstetric Complications → Recurrent miscarriages, preeclampsia, fetal growth restriction.
Transient Positivity → May be due to infections, certain medications, or recent inflammation.
✔ Anti-Phospholipid IgG & IgA Antibodies → IgG is more specific for APS.
✔ Lupus Anticoagulant (LA) Test → Strongest predictor of clotting risk in APS.
✔ Anti-Cardiolipin Antibodies (IgG, IgM, IgA) → Common in APS.
✔ Beta-2 Glycoprotein I Antibodies (IgG, IgM, IgA) → Highly specific for APS.
✔ Coagulation Tests (PT, aPTT, dRVVT) → Assess clotting abnormalities.
🔹 Repeat testing after 12 weeks to confirm persistence.
🔹 Check for blood clot history (DVT, PE, stroke, heart attack).
🔹 Pregnancy monitoring for women with recurrent miscarriages or preeclampsia.
🔹 Consider referral to a rheumatologist or hematologist for APS evaluation.
🔹 Anticoagulation therapy (warfarin, heparin, aspirin) may be needed if clotting risk is high.